跳至主要内容
临床试验/NCT06693947
NCT06693947已完成不适用

A Pilot Study in the Swiss Alps: Impact of Alpine Dairy Products on Blood Lipid Levels

University of Fribourg2 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2024年8月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
29
试验地点
2
主要终点
Change in fasting blood LDL-cholesterol level

研究概览

简要总结

Elevated blood lipid levels are one of the main risk factors for cardiovascular disease. To manage elevated blood lipid levels in otherwise healthy people at low risk of cardiovascular disease, lifestyle changes are recommended as the first treatment strategy. One of these changes concerns diet. Clinical observations by general practitioners in alpine regions of Switzerland have shown that consumption of dairy products produced from cows living and grazing at high altitudes can have a beneficial effect on blood lipid parameters. However, little clinical data is available on the effect of alpine dairy products on health-related markers. This pilot study aims to assess if replacing standard (non-alpine) dairy products by alpine dairy products in the daily diet among patients with elevated LDL-cholesterol levels could reduce the blood LDL-cholesterol levels.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years old
  • Elevated lipid levels, namely: fasting LDL-cholesterol >3mmol/L and </=5mmol/L
  • Agreeing to eat 3 portions of dairy products daily (according to instructions)

排除标准

  • Eating less than two and more than six portions of dairy products daily
  • Body weight change +/-5% of body weight in the last three months
  • Secondary prevention treatment for cardiovascular disease
  • Moderate, high or very high cardiovascular risk according to AGLA score
  • Currently taking PSCK9-inhibitors, ezetimibe, statins, glucocorticoids
  • Poorly controlled, severe chronic renal insufficiency, hypothyroidism, cholestasis, nephrotic syndrome, eating disorders, alcohol abuse, Cushing syndrome
  • Myocardial infarction, percutaneous coronary intervention or coronary artery bypass grafting in the previous 6 months
  • Known lactose intolerance or dairy allergies
  • Change of diet less than 2 months before intervention
  • Pregnant or breastfeeding
  • Incapacity of judgement
  • Inability to speak and read German

结局指标

主要结局

Change in fasting blood LDL-cholesterol level

时间窗: Baseline, Day 15, Day 30 and Day 45

Measure of LDL-cholesterol in mmol/L

次要结局

  • Change in total cholesterol, triglycerides, HDL-cholesterol and lipoprotein A(Baseline, Day 15, Day 30 and Day 45)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验